Asclepius Life Sciences Fund LP — Form D
Asclepius Life Sciences Fund LP of NEW YORK, NY, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2019-08-21. $1.5M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2019-08-21
- Form: D
- Accession: 0001786055-19-000001
- Industry: Pooled Investment Fund
- Exemptions: 06c
- Amount sold: $1.5M
- Minimum investment: $250K
- Investors: 6
- Date of first sale: 2016-10-31
- Security types: fund interests
- Revenue range: No Revenues
- SEC file number: 021-347078
Issuer
- Name: Asclepius Life Sciences Fund LP
- CIK: 0001786055
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2016
- Address: 641 LEXINGTON AVENUE, NEW YORK, NY, 10022
- Phone: 212-634-6440
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Stephen Charles Glover | Director | Weston, FL |
More